“I think members respond to certain incentives, but it has to be kept at a pretty simple level for them so that they can comprehend it and know what behavior the plan sponsor’s looking for. An eight-tier formulary, for example, sounds like a communication nightmare.”
— Brian Bullock, president and CEO of The Burchfield Group, Inc., told AIS’s Drug Benefit News.
No comments:
Post a Comment